Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01345344 · ClinicalTrials.gov registry record · NA
Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT01345344 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 148 participants.
The verdict
NCT01345344, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
This study design has two components: 1) a cross sectional assessment of brain connectivity and response to pain in healthy controls and demographically matched fibromyalgia patients, and 2) a longitudinal assessment of the same outcomes in fibromyalgia patients randomized to either CBT (Cognitive Behavioral Therapy) or a Disease Education condition. The investigators will evaluate a group of fibromyalgia patients who will receive CBT treatment once a week for 8 weeks, for a total of 8 treatments. Baseline data from these patients will be compared to results from pain-free controls and a group of education program controls. Participants will undergo experimental pain assessments as well as brain neuroimaging.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Disease Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2014-12 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01345344
The ClinicalTrials.gov registry entry for NCT01345344 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01345344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01345344 about?
NCT01345344 is a clinical study titled "Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia". This study design has two components: 1) a cross sectional assessment of brain connectivity and response to pain in healthy controls and demographically matched fibromyalgia patients, and 2) a longitudinal assessment of the same outcomes in fibromyalgia patients randomized to either CBT (Cognitive B...
What is the current status of trial NCT01345344?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2014-12. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT01345344?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Disease Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01345344?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.